123 related articles for article (PubMed ID: 29697655)
1. [About the safety of application of nasal decongestants in the practice of pediatricians].
Karpova EP; Tulupov DA; Vorob'eva MP; Fedotov FA; Dolginov DM; Bykov MV; Grabovskaya VA
Vestn Otorinolaringol; 2018; 83(2):46-50. PubMed ID: 29697655
[TBL] [Abstract][Full Text] [Related]
2. Naphazoline intoxication in a child-a clinical and forensic toxicological case.
Musshoff F; Gerschlauer A; Madea B
Forensic Sci Int; 2003 Jul; 134(2-3):234-7. PubMed ID: 12850424
[TBL] [Abstract][Full Text] [Related]
3. Ischemic stroke in a man with naphazoline abuse history.
Costantino G; Ceriani E; Sandrone G; Montano N
Am J Emerg Med; 2007 Oct; 25(8):983.e1-2. PubMed ID: 17920988
[No Abstract] [Full Text] [Related]
4. Bilateral thalamic stroke due to nasal ephedrine and naphazoline use.
Liguori C; Garaci F; Romigi A; Mercuri NB; Marciani MG; Placidi F
Neurol Sci; 2015 Jul; 36(7):1285-6. PubMed ID: 25527367
[No Abstract] [Full Text] [Related]
5. Intranasal lidocaine plus naphazoline nitrate improves surgical conditions and perioperative analgesia in septorhinoplasty surgery.
Granier M; Dadure C; Bringuier S; Bonnet-Boyer MC; Ryckwaert Y; Loriaux E; Capdevila X
Can J Anaesth; 2009 Feb; 56(2):102-8. PubMed ID: 19247757
[TBL] [Abstract][Full Text] [Related]
6. [Electron microscopic studies of the rabbit nasal mucosa after short-term application of naphzoline nitrate].
Agha-Mir-Salim P; Stange T; Knipping S; Jahnke V; Berghaus A
Laryngorhinootologie; 2001 Jul; 80(7):389-93. PubMed ID: 11488150
[TBL] [Abstract][Full Text] [Related]
7. Do topical nasal decongestants affect polyps?
Johansson L; Oberg D; Melén I; Bende M
Acta Otolaryngol; 2006 Mar; 126(3):288-90. PubMed ID: 16618656
[TBL] [Abstract][Full Text] [Related]
8. [Severe poisoning with naphazoline: update from a therapeutic error].
Díaz M; Granson E; Taiman J; Alava J; Gabrielli T; Mendoza L
Arch Argent Pediatr; 2018 Aug; 116(4):e626-e629. PubMed ID: 30016045
[TBL] [Abstract][Full Text] [Related]
9. [Nasal decongestants and eye drops: keep out of children's reach!].
Poulin-Chartrand S
Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872
[No Abstract] [Full Text] [Related]
10. Acute coronary syndrome after nasal spray of oxymetazoline.
Montastruc F; Montastruc G; Taudou MJ; Olivier-Abbal P; Montastruc JL; Bondon-Guitton E
Chest; 2014 Dec; 146(6):e214-e215. PubMed ID: 25451367
[No Abstract] [Full Text] [Related]
11. Medical Treatment of Nasal Airway Obstruction.
Cox DR; Wise SK
Otolaryngol Clin North Am; 2018 Oct; 51(5):897-908. PubMed ID: 29914725
[TBL] [Abstract][Full Text] [Related]
12. Naphazoline nasal drops intoxication in children.
Vitezić D; Rozmanić V; Franulović J; Ahel V; Matesić D
Arh Hig Rada Toksikol; 1994 Mar; 45(1):25-9. PubMed ID: 8067910
[TBL] [Abstract][Full Text] [Related]
13. [The use of laser Doppler flowmetry for the estimation of the influence of intranasal medications on microcirculation in nasal cavity mucosa].
Svistunov AA; Mareev OV; Mareev GO; Bukreev IS
Vestn Otorinolaringol; 2012; (3):34-8. PubMed ID: 22951682
[TBL] [Abstract][Full Text] [Related]
14. [Danger of nasal vasoconstrictors in infants. Apropos of a case].
Claudet I; Fries F
Arch Pediatr; 1997 Jun; 4(6):538-41. PubMed ID: 9239269
[TBL] [Abstract][Full Text] [Related]
15. Brazilian Academy of Rhinology position paper on topical intranasal therapy.
Mello JF; Mion Ode G; Andrade NA; Anselmo-Lima WT; Stamm AE; Almeida WL; Cavalcante Filho PO; Castro Jde C; Padua FG; Romano FR; Santos Rde P; Roitmann R; Voegels RL; Meirelles RC; Sá LC; Moacyr MT; Santos MC; Guimarães RE
Braz J Otorhinolaryngol; 2013; 79(3):391-400. PubMed ID: 23743757
[TBL] [Abstract][Full Text] [Related]
16. Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of use.
Passàli D; Salerni L; Passàli GC; Passàli FM; Bellussi L
Expert Opin Drug Saf; 2006 Nov; 5(6):783-90. PubMed ID: 17044805
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary edema and prolonged awakening after nasal naphazoline application in a transspenoidal hypophysectomy patient.
Klein KU; Wisser G; Engelhard K; Werner C
J Neurosurg Anesthesiol; 2010 Jul; 22(3):269. PubMed ID: 20548172
[No Abstract] [Full Text] [Related]
18. Oxymetazoline nasal spray.
Graf P
Laryngoscope; 1998 Aug; 108(8 Pt 1):1255. PubMed ID: 9707257
[No Abstract] [Full Text] [Related]
19. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion.
Stübner UP; Toth J; Marks B; Berger UE; Burtin B; Horak F
Arzneimittelforschung; 2001 Nov; 51(11):904-10. PubMed ID: 11765592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
